V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270013225 | 270016746 | 1.61 | 36.3 | Neo-adjuvant (N) | 2015-11-02 | 2015-11-04 | COPP + Dacarbazine | null | null | 270014373 | COPP + DACARBAZINE |
| 270013226 | 270008759 | 1.33 | 93.8 | Disease modification (D) | 2015-08-26 | 2015-08-26 | HD EuroNet-PHL-C1 COPDAC | null | N | 270014375 | TRIAL |
| 270013227 | 270008760 | 0 | 72 | Adjuvant (A) | 2015-05-28 | 2015-05-28 | COPP + Dacarbazine | N | N | 270014375 | COPP + DACARBAZINE |
| 270013228 | 270008760 | 1.75 | 79.4 | Palliative (P) | 2012-11-25 | 2013-01-26 | Cetuximab 7 day (Cycle 1) | 02 | N | 270014375 | CETUXIMAB |
| 270013229 | 270014138 | 1.8 | null | Adjuvant (A) | 2014-10-20 | 2014-11-19 | CETUXIMAB | N | N | 270014386 | CETUXIMAB |
| 270013230 | 270014138 | 0 | 73.5 | Adjuvant (A) | 2017-09-02 | 2017-09-06 | COPP + Dacarbazine | 02 | N | 270014386 | COPP + DACARBAZINE |
| 270013231 | 270019620 | 1.73 | 51 | Palliative (P) | 2016-06-08 | 2016-07-03 | Cetuximab 7 day (>Cycle 2) | N | N | 270014390 | CETUXIMAB |
| 270013232 | 270008762 | 1.76 | 78 | Adjuvant (A) | 2017-04-01 | 2017-04-02 | COPP + Dacarbazine | N | N | 270014393 | COPP + DACARBAZINE |
| 270013233 | 270014139 | 1.63 | 68 | null | 2013-05-11 | 2013-07-12 | COPP + Dacarbazine | 02 | N | 270014396 | COPP + DACARBAZINE |
| 270013234 | 270008764 | null | 49.7 | Curative (C) | 2014-12-25 | 2015-03-11 | BEACOPP-14 | N | N | 270014396 | BEACOPP |
| 270013235 | 270008764 | 1.65 | 62.3 | null | null | 2013-06-24 | Escalated BEACOPP | N | N | 270014396 | BEACOPP |
| 270013236 | 270008764 | 1.81 | 109.2 | null | 2015-12-04 | 2015-12-11 | BEACOPP-14 | N | N | 270014396 | BEACOPP |
| 270013237 | 270008764 | null | 47.2 | Neo-adjuvant (N) | 2015-12-26 | 2016-01-27 | CETUXIMAB | N | N | 270014396 | CETUXIMAB |
| 270013238 | 270008766 | 1.81 | 79.6 | Palliative (P) | 2016-11-30 | 2016-11-30 | HD EuroNet-PHL-C1 COPDAC | N | N | 270014407 | TRIAL |
| 270013239 | 270008767 | 1.79 | 77 | Palliative (P) | 2017-11-20 | 2017-12-06 | CETUXIMAB + IRINOTECAN + MDG | 2 | N | 270014409 | CETUXIMAB + IRINOTECAN + MDG |
| 270013240 | 270008770 | 1.71 | 67.7 | null | 2016-11-01 | 2016-11-07 | ESHAP | N | N | 270014411 | ESHAP |
| 270013241 | 270008773 | 1.54 | 46 | Curative (C) | 2017-07-05 | 2017-07-07 | Rituximab | N | N | 270014412 | RITUXIMAB |
| 270013242 | 270008776 | 1.8 | 73.2 | Curative (C) | 2017-05-11 | 2017-05-29 | Cisplatin + Radiotherapy | 02 | N | 270014414 | CISPLATIN + RT |
| 270013243 | 270008777 | 1.7 | 49.9 | Curative (C) | 2017-03-02 | 2017-03-02 | Cetuximab + FOLFIRI cycle 2 onwards | N | N | 270014415 | CETUXIMAB + IRINOTECAN + MDG |
| 270013244 | 270008778 | 1.73 | 60 | Curative (C) | 2016-12-07 | 2016-12-07 | HD EuroNet-PHL-C1 OEPA | N | N | 270014417 | OEPA |
| 270013245 | 270008779 | 1.88 | 71.4 | null | 2015-09-01 | 2015-09-04 | OEPA | 02 | N | 270014418 | OEPA |
| 270013246 | 270018260 | 1.72 | 109.3 | Curative (C) | 2013-05-25 | 2013-05-25 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270014418 | CISPLATIN + RT |
| 270013247 | 270018260 | 1.64 | 95.4 | Curative (C) | 2018-01-09 | 2018-01-09 | Cisplatin 100 + RT(H&N) 1 day | N | N | 270014418 | CISPLATIN + RT |
| 270013248 | 270008785 | 0 | 73.05 | Palliative (P) | 2017-01-30 | 2017-02-07 | CETUXIMAB + IRINOTECAN + MDG | N | N | 270014428 | CETUXIMAB + IRINOTECAN + MDG |
| 270013249 | 270008786 | 1.65 | 69 | Curative (C) | 2014-11-07 | 2014-11-28 | Rituximab | 02 | N | 270014429 | RITUXIMAB |
| 270013250 | 270008787 | 1.72 | 60.3 | Curative (C) | 2016-12-21 | 2016-12-21 | CISPLATIN + RT | 02 | N | 270014430 | CISPLATIN + RT |
| 270013251 | 270008788 | 1.48 | 52.2 | Curative (C) | null | 2013-05-08 | OEPA | N | N | 270014432 | OEPA |
| 270013252 | 270008791 | null | 64.2 | Curative (C) | 2015-05-22 | 2015-06-04 | ESHAP | 2 | N | 270014433 | ESHAP |
| 270013253 | 270008792 | 1.78 | 83.2 | null | 2017-09-05 | 2017-09-05 | Rituximab | 2 | N | 270014433 | RITUXIMAB |
| 270013254 | 270008793 | 1.91 | 79.4 | Curative (C) | 2014-09-26 | 2014-10-03 | CETUXIMAB + IRINOTECAN + MDG | N | Y | 270014439 | CETUXIMAB + IRINOTECAN + MDG |
| 270013255 | 270008794 | 1.66 | 62.9 | Curative (C) | 2017-01-10 | 2017-01-11 | OEPA | 02 | N | 270014444 | OEPA |
| 270013256 | 270019623 | 2 | 67.3 | Curative (C) | 2018-01-17 | 2018-01-17 | OEPA | null | N | 270014445 | OEPA |
| 270013257 | 270014148 | 1.71 | 65.9 | Curative (C) | 2015-08-28 | 2015-09-01 | Rituximab | N | N | 270014446 | RITUXIMAB |
| 270013258 | 270014149 | 1.48 | 47.4 | Curative (C) | 2015-12-10 | 2016-01-07 | CISPLATIN + RT | 2 | N | 270014449 | CISPLATIN + RT |
| 270013259 | 270008799 | null | 46.5 | Palliative (P) | 2016-09-20 | 2016-10-03 | Cetuximab + FOLFIRI cycle 2 onwards | 02 | null | 270014452 | CETUXIMAB + IRINOTECAN + MDG |
| 270013260 | 270014150 | 1.68 | null | Curative (C) | 2014-09-30 | 2015-05-17 | BEAM | 02 | N | 270014460 | BEAM |
| 270013261 | 270014150 | 1.82 | 72 | Curative (C) | 2014-07-01 | 2014-09-07 | Rituximab | N | Y | 270014460 | RITUXIMAB |
| 270013262 | 270008803 | 1.62 | 133.6 | Curative (C) | 2011-09-29 | 2014-04-10 | ESHAP | N | N | 270014466 | ESHAP |
| 270013263 | 270014151 | 1.83 | 105.2 | Curative (C) | 2013-11-24 | 2013-11-28 | BEAM | 02 | N | 270014466 | BEAM |
| 270013264 | 270008805 | 1.76 | 97.3 | Curative (C) | 2017-08-24 | 2017-08-31 | HD EuroNet-PHL-C1 OEPA | 02 | N | 270014467 | OEPA |
| 270013265 | 270008805 | 1.6 | 64.1 | Curative (C) | 2015-12-07 | 2016-05-20 | Rituximab | N | N | 270014467 | RITUXIMAB |
| 270013266 | 270008809 | 1.79 | 65.8 | Curative (C) | 2013-12-30 | 2014-01-05 | Rituximab (Maintenance) | N | Y | 270014477 | RITUXIMAB |
| 270013267 | 270008809 | 1.72 | 75.6 | Curative (C) | 2013-06-07 | 2013-06-21 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 270014477 | CISPLATIN + RT |
| 270013268 | 270016757 | 1.89 | 59.699 | Curative (C) | 2013-08-06 | 2013-08-26 | BEAM | N | N | 270014485 | BEAM |
| 270013271 | 270008814 | 1.65 | 88.6 | Curative (C) | 2013-05-29 | 2013-05-29 | Rituximab | N | N | 270014492 | RITUXIMAB |
| 270013272 | 270008815 | 0 | 92.8 | Curative (C) | 2017-09-26 | 2017-10-04 | HD EuroNet-PHL-C1 OEPA | 02 | N | 270014494 | OEPA |
| 270013273 | 270008819 | 1.84 | 60.3 | Curative (C) | 2015-11-13 | 2015-11-19 | LEAM | Y | N | 270014498 | LEAM |
| 270013274 | 270008820 | 1.71 | 57.8 | Curative (C) | 2017-04-14 | 2017-04-15 | Rituximab | 02 | N | 270014503 | RITUXIMAB |
| 270013275 | 270008820 | 1.76 | 85.7 | Curative (C) | 2016-05-07 | 2016-05-07 | Rituximab (Maintenance) | N | N | 270014503 | RITUXIMAB |
| 270013276 | 270008821 | 1.7 | 62.4 | Curative (C) | 2015-01-21 | 2015-01-21 | CISPLATIN + RT | N | N | 270014508 | CISPLATIN + RT |